Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation
- PMID: 29718999
- PMCID: PMC5951585
- DOI: 10.1371/journal.ppat.1007024
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation
Abstract
The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free holes large enough to admit broadly neutralizing antibodies (bnAb). Consequently, most bnAbs must inevitably make some glycan contacts and avoid clashes with others. To investigate how Env glycan maturation regulates HIV sensitivity to bnAbs, we modified HIV-1 pseudovirus (PV) using various glycoengineering (GE) tools. Promoting the maturation of α-2,6 sialic acid (SA) glycan termini increased PV sensitivity to two bnAbs that target the V2 apex and one to the interface between Env surface gp120 and transmembrane gp41 subunits, typically by up to 30-fold. These effects were reversible by incubating PV with neuraminidase. The same bnAbs were unusually potent against PBMC-produced HIV-1, suggesting similar α-2,6 hypersialylated glycan termini may occur naturally. Overexpressing β-galactosyltransferase during PV production replaced complex glycans with hybrid glycans, effectively 'thinning' trimer glycan coverage. This increased PV sensitivity to some bnAbs but ablated sensitivity to one bnAb that depends on complex glycans. Other bnAbs preferred small glycans or galactose termini. For some bnAbs, the effects of GE were strain-specific, suggesting that GE had context-dependent effects on glycan clashes. GE was also able to increase the percent maximum neutralization (i.e. saturation) by some bnAbs. Indeed, some bnAb-resistant strains became highly sensitive with GE-thus uncovering previously unknown bnAb breadth. As might be expected, the activities of bnAbs that recognize glycan-deficient or invariant oligomannose epitopes were largely unaffected by GE. Non-neutralizing antibodies were also unaffected by GE, suggesting that trimers remain compact. Unlike mature bnAbs, germline-reverted bnAbs avoided or were indifferent to glycans, suggesting that glycan contacts are acquired as bnAbs mature. Together, our results suggest that glycovariation can greatly impact neutralization and that knowledge of the optimal Env glycoforms recognized by bnAbs may assist rational vaccine design.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.J Virol. 2015 Sep;89(17):8932-44. doi: 10.1128/JVI.01190-15. Epub 2015 Jun 17. J Virol. 2015. PMID: 26085151 Free PMC article.
-
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.PLoS Pathog. 2018 Nov 5;14(11):e1007431. doi: 10.1371/journal.ppat.1007431. eCollection 2018 Nov. PLoS Pathog. 2018. PMID: 30395637 Free PMC article.
-
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.J Virol. 2017 Nov 30;91(24):e01216-17. doi: 10.1128/JVI.01216-17. Print 2017 Dec 15. J Virol. 2017. PMID: 28978711 Free PMC article.
-
The HIV glycan shield as a target for broadly neutralizing antibodies.FEBS J. 2015 Dec;282(24):4679-91. doi: 10.1111/febs.13530. Epub 2015 Oct 23. FEBS J. 2015. PMID: 26411545 Free PMC article. Review.
-
Antibody responses to the HIV-1 envelope high mannose patch.Adv Immunol. 2019;143:11-73. doi: 10.1016/bs.ai.2019.08.002. Epub 2019 Sep 11. Adv Immunol. 2019. PMID: 31607367 Free PMC article. Review.
Cited by
-
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep. PLoS Pathog. 2019. PMID: 31527908 Free PMC article.
-
Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery.ACS Pharmacol Transl Sci. 2024 Feb 21;7(3):614-629. doi: 10.1021/acsptsci.3c00397. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481692 Review.
-
Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.Chembiochem. 2022 Aug 17;23(16):e202200236. doi: 10.1002/cbic.202200236. Epub 2022 Jun 20. Chembiochem. 2022. PMID: 35647713 Free PMC article.
-
Glycosylation of Antigen-Specific Antibodies: Perspectives on Immunoglobulin G Glycosylation in Vaccination and Immunotherapy.Exp Suppl. 2021;112:565-587. doi: 10.1007/978-3-030-76912-3_18. Exp Suppl. 2021. PMID: 34687023
-
Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma.Virology. 2023 May;582:62-70. doi: 10.1016/j.virol.2023.03.011. Epub 2023 Mar 30. Virology. 2023. PMID: 37030154 Free PMC article.
References
-
- Mascola JR, Montefiori DC. The role of antibodies in HIV vaccines. Annu Rev Immunol. 2010;28:413–44. Epub 2010/03/03. doi: 10.1146/annurev-immunol-030409-101256 . - DOI - PubMed
-
- Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, Gorman J, et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature. 2014;514(7523):455–61. doi: 10.1038/nature13808 . - DOI - PMC - PubMed
-
- Lee JH, Ozorowski G, Ward AB. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science. 2016;351(6277):1043–8. doi: 10.1126/science.aad2450 . - DOI - PMC - PubMed
-
- Stewart-Jones GB, Soto C, Lemmin T, Chuang GY, Druz A, Kong R, et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. Cell. 2016;165(4):813–26. doi: 10.1016/j.cell.2016.04.010 - DOI - PMC - PubMed
-
- Gristick HB, von Boehmer L, West AP Jr., Schamber M, Gazumyan A, Golijanin J, et al. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site. Nat Struct Mol Biol. 2016;23(10):906–15. doi: 10.1038/nsmb.3291 . - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous